Desarrollo y validación de un instrumento observacional para la evaluación del bienestar en personas con demencia desde la perspectiva de la atención centrada en la persona: Listado de Indicadores de Bienestar / Development and validation of an observational tool for the assessment of well-being in people with dementia from the perspective of Person Centred Care: list of Well-being Indicators of Wellbeing

INTRODUCCIÓN: En el contexto del modelo de atención centrada en la persona, se expone la creación y validación de un instrumento observacional para la evaluación del bienestar en personas con demencia, desde una perspectiva que pretende destacar los efectos que el entorno físico y social tienen en la persona, y cómo se reflejan en su bienestar. MATERIAL Y MÉTODO: El Listado de Indicadores de Bienestar (LIBE) se creó siguiendo un proceso inductivo iterativo con profesionales de distintas disciplinas, hasta llegar a la versión validada. Se validó en dos estudios sucesivos con una muestra de 79 personas con demencia. Se realizaron análisis de capacidad de discriminación de los indicadores que componen la escala, consistencia interna, fiabilidad interjueces, y validez convergente y discriminante. RESULTADOS: Se obtuvo una consistencia interna α de Cronbach de 0,81. Respecto a la fiabilidad interjueces, el CCI hallado entre los 3 evaluadores fue significativo para todos los indicadores con puntuaciones entre 0,59 y 1,00. Se estudió la validez convergente comparando las puntuaciones en cada indicador de LIBE con las puntuaciones en cada ítem de QUALID, y se encontraron asociaciones significativas entre la categoría de respuesta en ciertos ítems de QUALID y la categoría de respuesta en ciertos indicadores de LIBE. Para la validez discriminante se compararon las puntuaciones obtenidas en cada indicador de LIBE con las puntuaciones en cada ítem de PAINAD-Sp, y no se encontró ninguna asociación significativa. CONCLUSIÓN: LIBE ofrece una medida observacional de conductas consideradas indicadores de bienestar en personas con demencia que viven en centros residenciales. Es un instrumento válido y fiable, que ofrece una perspectiva diferente de medida de un constructo poco explorado en las poblaciones con demencia. Es un instrumento fácil de aplicar, con distintos usos (clínicos, de intervención, de investigación), y aplicable por profesionales de distintas disciplinas

INTRODUCTION: Within the context of Person Centred Care, the present paper shows the creation and validation process of an observational tool for the assessment of the wellbeing of people with dementia, from a perspective that seeks to highlight the effects that the physical and social environment have on the person, and how these are reflected in the well-being. METHODS: The List of Wellbeing Indicators (LIBE) was created following an inductive iterative process with professionals from different disciplines, until the validated version was reached. It was then validated in two successive studies with a sample of 79 people with dementia. Discrimination capacity of the scale indicators, internal consistency, inter-rater reliability, and convergent and divergent validity were determined. RESULTS: An internal consistency of Cronbach́s alpha 0.81 was obtained. The inter-rater reliability, analysing intraclass correlation coefficient (ICC) within the 3 raters, was significant for all the indicators in the tool, with scores between 0.59-1.00. Convergent validity was studied comparing scores in each LIBE indicator with scores in each QUALID indicator, and some significant associations were found between response categories in both tools. For the discriminant validity, the scores obtained in each LIBE indicator were compared with the scores in each PAINAD-Sp item, and no significant associations were found. CONCLUSION: LIBE offers an observational measure of behaviours that can be considered well-being indicators in people with dementia living in residential care. LIBE is a valid and reliable tool that offers a different perspective of measuring a construct that has been infrequently explored in dementia population. Is also an easy to apply tool, with different uses (clinical, intervention, research), and applicable for professionals of several disciplines

[Development and validation of an observational tool for the assessment of well-being in people with dementia from the perspective of Person Centred Care: List of Well-being Indicators of Wellbeing]. / Desarrollo y validación de un instrumento observacional para la evaluación del bienestar en personas con demencia desde la perspectiva de la atención centrada en la persona: Listado de Indicadores de Bienestar.

INTRODUCTION: Within the context of Person Centred Care, the present paper shows the creation and validation process of an observational tool for the assessment of the wellbeing of people with dementia, from a perspective that seeks to highlight the effects that the physical and social environment have on the person, and how these are reflected in the well-being. METHODS: The List of Wellbeing Indicators (LIBE) was created following an inductive iterative process with professionals from different disciplines, until the validated version was reached. It was then validated in two successive studies with a sample of 79 people with dementia. Discrimination capacity of the scale indicators, internal consistency, inter-rater reliability, and convergent and divergent validity were determined. RESULTS: An internal consistency of Cronbach́s alpha 0.81 was obtained. The inter-rater reliability, analysing intraclass correlation coefficient (ICC) within the 3 raters, was significant for all the indicators in the tool, with scores between 0.59-1.00. Convergent validity was studied comparing scores in each LIBE indicator with scores in each QUALID indicator, and some significant associations were found between response categories in both tools. For the discriminant validity, the scores obtained in each LIBE indicator were compared with the scores in each PAINAD-Sp item, and no significant associations were found. CONCLUSION: LIBE offers an observational measure of behaviours that can be considered well-being indicators in people with dementia living in residential care. LIBE is a valid and reliable tool that offers a different perspective of measuring a construct that has been infrequently explored in dementia population. Is also an easy to apply tool, with different uses (clinical, intervention, research), and applicable for professionals of several disciplines.

Estudio Palidem: cuidados al final de la vida en pacientes con demencia avanzada institucionalizados / The Palidem study: care at the end of life in institutionalized patients with advanced dementia

OBJETIVO: Desarrollar un plan de atención específi co en pacientes con demencia avanzada institucionalizados, planificando los cuidados mediante el control sintomático, tomando decisiones con el cuidador principal, realizando un apoyo psicológico y espiritual. MÉTODO: Estudio descriptivo de periodo en el Centro Txara 1, desde el 1 de julio de 2014 hasta el 31 de diciembre de 2016, identifi cando a aquellos residentes con demencia avanzada y síndrome de declive. Se recoge trimestralmente el grado de control de síntomas (Symptom Management at the End-of-Life in Dementia) (SM-EOLD), utilizando la escala PAINAD para la valoración del dolor; el confort en el momento de la agonía se determina diariamente (The Comfort Assessment in Dying with Dementia) (CAD-EOLD), estableciendo con el cuidador principal la toma de decisiones basadas en los objetivos asistenciales paliativos. Tras el fallecimiento se realiza una encuesta de satisfacción al cuidador (Satisfaction with Care at the End-of-Life in Dementia) (SWC-EOLD) y contacto periódico con la pastoral para el apoyo espiritual. RESULTADOS: Se han analizado 74 residentes, con una edad media de 87 años, un 79 % mujeres, con 4,6 medicamentos de media, con enfermedad de Alzheimer como principal causa de demencia. En el control de síntomas en fase estable no se detecta inestabilidad física o conductual relevante, detectándose en un 5 % la presencia de dolor. De 50 residentes fallecidos, el 94 % sucede en el propio centro, en un 67 % se puede registrar el grado de confort destacando la presencia de disnea y disfagia, al ser la infección respiratoria aspirativa la principal causa de fallecimiento. En un 66 % de la población seleccionada se realiza atención espiritual. Un 30 % de los cuidadores principales responden a la encuesta de satisfacción, con un alto porcentaje de aceptación en el nivel de cuidados. CONCLUSIONES: La identificación de los pacientes con demencia avanzada en situación de final de vida permite estructurar un plan de atención en el centro gerontológico, conociendo las necesidades sintomáticas, el grado de confort o bienestar y consensuando las decisiones en cuanto a la proporcionalidad de cuidados con la familia. Ante situaciones de descompensación aguda, la coordinación con los recursos sociosanitarios disponibles es fundamental para poder llevar a cabo las decisiones adoptadas del equipo sanitario con el cuidador principal

OBJECTIVE: To develop a specific care plan for institutionalized patients with advanced dementia based on symptom control and including joint decision making with the primary caregiver as well as psychological and spiritual support. METHOD: A descriptive 1-period study at Centro Txara 1, from July 1 2014 to December 31 2016, which identified residents with advanced dementia and geriatric failure-to-thrive syndrome. Symtom control extent was quarterly assessed using the Symptom Management at the End-of-Life in Dementia (SM-EOLD) scale, and the PAINAD scale for pain; comfort at the end of life was assessed daily with the Comfort Assessment in Dying with Dementia (CAD-EOLD) instrument, and decisions were made jointly with the primary caregiver based on the goals of palliative care. After the death of the patient a satisfaction survey was administered to the caregiver (Satisfaction with Care at the End-of-Life in Dementia, SWC-EOLD), who was also provided with regular contact with the pastoral care team for spiritual support. RESULTS: A total of 74 residents were assessed with a mean age of 87 years; 79% were females, mean number of drugs was 4.6, and Alzheimer's disease was the primary cause of dementia. Stable-phase symptom control identified no relevant phisical or behavioral instability, but pain was found in 5% of the sample. Of 50 residents who passed away, 94% died in the hospice; in 67% comfort degree could be collected, and the presence of shortness of breath and dysphagia stood out, as aspiration-induced respiratory infection was the primary cause of death. Spiritual care was provided for 66% of the study population. In all, 30% of primary caregivers responded to the satisfaction survey showing a high percentage of acceptance of level of care. CONCLUSIONS: Identifying patients with advanced dementia at the end of life allows the development of a hospice care plan considering symptom needs, comfort degree and wellbeing, and involving consensus decisions about care proportionality with the family. Should an acute decompensation occur, coordination with the available social and healthcare resources is key for implementing the decisions agreed between the healthcare team and the primary caregiver

Evaluación cognitiva global en personas vascoparlantes con demencia en estadios avanzados. Validación al euskera de la escala Severe Mini Mental State Examination (SMMSE-eus) / Overal cognitive assessment in Basque-speaking people with advanced dementia. Validation to the Basque language of the Severe Mini-Mental State Examination SMMSE (SMMSE-eus)

Introducción: La adaptación y validación al euskera de pruebas para la evaluación del deterioro cognitivo avanzado es una necesidad no cubierta para personas mayores vascoparlantes. El presente trabajo realiza el estudio de validación al euskera de la escala Severe Mini Mental State Examination (SMMSE-eus). Material y métodos: En el estudio participaron 109 sujetos con demencia avanzada (MEC<15) clasificados según la escala de Deterioro global (GDS) con GDS 5-7 y que dominaban tanto el euskera como el castellano. Resultados: Los resultados mostraron que el SMMSE-eus muestra una alta consistencia interna (α=0,92), una buena fiablidad test-restest (r=0,88; p<0,01) y una alta fiabilidad interjueces (CCI=0,99; p<0,00) tanto para la puntuación global como para cada uno de los ítems. Conclusiones: Tanto la alta consistencia interna como el alto nivel de fiabilidad interjueces y los resultados obtenidos en el test-retest hacen del SMMSE-eus un instrumento apropiado como escala breve en la valoración del deterioro cognitivo grave de personas vascoparlantes. Por ello el SMMSE-eus puede ser considerado válido, fiable y una alternativa importante para evaluar en su lengua materna, en este caso en euskera, la capacidad cognitiva en personas con demencia avanzada

Introduction: Adaptation and validation to the Basque language of tests to assess advanced cognitive impairment is a not covered need for Basque-speaking people. The present work shows the validation of the Basque version of the Severe Mini Mental State Examination (SMMSE). Material and methods: A total of 109 people with advanced dementia (MEC<15) took part in the validation study, and were classified as GDS 5-7 on the Geriatric Depression Scale (GDS). All participants were Spanish-Basque bilingual. Results: It was shown that SMMSE-eus has a high internal consistency (alpha=0.92), a good test-retest reliability (r=0.88; P<.01), and a high inter-rater reliability (CCI=0.99; P<.00) for the overall score, as well as for each item. Conclusions: Both the high internal consistency and inter-rater reliability, and to a lesser extent, test-retest reliability, made the SMMSE-eus a valid test for the brief assessment of cognitive status in people with advanced dementia in Basque-speaking people. For this reason, the SMMSE-eus is a usable and reliable alternative for assessing Basque-speaking people in their mother-tongue, or preferred language

[Overal cognitive assessment in Basque-speaking people with advanced dementia. Validation to the Basque language of the Severe Mini-Mental State Examination SMMSE (SMMSE-eus)]. / Evaluación cognitiva global en personas vascoparlantes con demencia en estadios avanzados. Validación al euskera de la escala Severe Mini Mental State Examination (SMMSE-eus).

INTRODUCTION: Adaptation and validation to the Basque language of tests to assess advanced cognitive impairment is a not covered need for Basque-speaking people. The present work shows the validation of the Basque version of the Severe Mini Mental State Examination (SMMSE). MATERIAL AND METHODS: A total of 109 people with advanced dementia (MEC<15) took part in the validation study, and were classified as GDS 5-7 on the Geriatric Depression Scale (GDS). All participants were Spanish-Basque bilingual. RESULTS: It was shown that SMMSE-eus has a high internal consistency (alpha=0.92), a good test-retest reliability (r=0.88; P<.01), and a high inter-rater reliability (CCI=0.99; P<.00) for the overall score, as well as for each item. CONCLUSIONS: Both the high internal consistency and inter-rater reliability, and to a lesser extent, test-retest reliability, made the SMMSE-eus a valid test for the brief assessment of cognitive status in people with advanced dementia in Basque-speaking people. For this reason, the SMMSE-eus is a usable and reliable alternative for assessing Basque-speaking people in their mother-tongue, or preferred language.

Signatures of α clustering in light nuclei from relativistic nuclear collisions.

We argue that relativistic nuclear collisions may provide experimental evidence of α clustering in light nuclei. A light α-clustered nucleus has a large intrinsic deformation. When collided against a heavy nucleus at very high energies, this deformation transforms into the deformation of the fireball in the transverse plane. The subsequent collective evolution of the fireball leads to harmonic flow reflecting the deformation of the initial shape, which can be measured with standard methods of relativistic heavy-ion collisions. We illustrate the feasibility of the idea by modeling the (12)C-(208)Pb collisions and point out that very significant quantitative and qualitative differences between the α-clustered and uniform (12)C nucleus occur in such quantities as the triangular flow, its event-by-event fluctuations, or the correlations of the elliptic and triangular flows. The proposal offers a possibility of studying low-energy nuclear structure phenomena with "snapshots" made with relativistic heavy-ion collisions.

Adaptación y validación de la versión española de la escala de evaluación de dolor en personas con demencia avanzada: PAINAD-Sp / Adaptation and validation of the Spanish version of the Pain Evaluation Scale in patients with advanced dementia: PAINAD-Sp

Introducción. El dolor está considerado como un grave problema en el entorno residencial afectando entre un 49 y un 83% de los residentes. El proceso evolutivo de la enfermedad de Alzheimer puede conllevar dificultades de comunicación y comprensión de las escalas de evaluación de dolor, dificultando su evaluación y tratamiento. El objetivo principal de este estudio fue validar la versión española del PAINAD (PAINAD-Sp) y evaluar su aplicabilidad en un Centro Gerontológico en España. Material y métodos. Veinte usuarias diagnosticadas de demencia avanzada fueron observadas por 5 observadores con diferentes perfiles profesionales durante 5 min en 3 condiciones: reposo, durante actividad agradable y en situación de dolor. La PAINAD-Sp fue administrada simultáneamente a una escala analógica visual. Resultados. Los resultados muestran que el alfa de Cronbach se encontraba entre 0,467 y 0,827 (con una media de 0,692, que subía si el ítem de respiración se eliminaba). La fiabilidad interjueces variaba entre 0,587 y 0,956. La correlación entre la medida total en PAINAD-Sp y en una Escala Visual Analógica fue estadísticamente significativa (p < 0,05) en todas las medidas y variaba entre 0,517 y 0,868. Conclusiones. Los resultados del estudio muestran que la escala PAINAD-Sp es eficaz para medir el dolor en personas con demencia sin capacidad de comunicación. Esta escala puede ser usada por diferentes profesionales de la salud con poco entrenamiento y presenta una buena fiabilidad (AU)

Introduction. Pain in elderly people is considered a major concern in nursing home facilities affecting between 49% and 83% of the residents. Progression of Alzheimer's Disease causes more communication difficulties in patients with advanced dementia and therefore more problems to understand even the most simple pain evaluation scales. Identification and implementation of appropriate pain management strategies depends on an adequate pain assessment. Material and methods. The main objective of the study was to validate the Spanish version of the PAINAD Scale (PAINAD-Sp) and to assess its applicability in Spanish Geriatric Nursing Homes. The 20 patients diagnosed with severe dementia from a Geriatric Centre in Spain were observed by five observers with different professional profiles for 5 minutes to each participant, and PAINAD-Sp Scale was administered simultaneously to a Visual Analogical Scale-VAS. Three different observational conditions were established: resting condition, during presumably pleasant activity and during presumable painful activity. Results. Cronbach's alpha ranged between 0.467 and 0.827 (average 0.692), and rose if Breathing item was deleted. Inter-rater reliability ranged between 0.587 and 0.956. Correlation between PAINAD-Sp Scale total measures and VAS was statistically significant (P<.05) in all measures and ranged from 0.517 to 0.868. Conclusions. Findings in the study showed that the scale is useful to measure pain in non communicative patients suffering from dementia. The scale maintains good levels of reliability for different healthcare professionals even when they have little training (AU)

[Adaptation and validation of the Spanish version of the Pain Evaluation Scale in patients with advanced dementia: PAINAD-Sp]. / Adaptación y validación de la versión española de la escala de evaluación de dolor en personas con demencia avanzada: PAINAD-Sp.

INTRODUCTION: Pain in elderly people is considered a major concern in nursing home facilities affecting between 49% and 83% of the residents. Progression of Alzheimer's Disease causes more communication difficulties in patients with advanced dementia and therefore more problems to understand even the most simple pain evaluation scales. Identification and implementation of appropriate pain management strategies depends on an adequate pain assessment. MATERIAL AND METHODS: The main objective of the study was to validate the Spanish version of the PAINAD Scale (PAINAD-Sp) and to assess its applicability in Spanish Geriatric Nursing Homes. The 20 patients diagnosed with severe dementia from a Geriatric Centre in Spain were observed by five observers with different professional profiles for 5 minutes to each participant, and PAINAD-Sp Scale was administered simultaneously to a Visual Analogical Scale-VAS. Three different observational conditions were established: resting condition, during presumably pleasant activity and during presumable painful activity. RESULTS: Cronbach's alpha ranged between 0.467 and 0.827 (average 0.692), and rose if Breathing item was deleted. Inter-rater reliability ranged between 0.587 and 0.956. Correlation between PAINAD-Sp Scale total measures and VAS was statistically significant (P<.05) in all measures and ranged from 0.517 to 0.868. CONCLUSIONS: Findings in the study showed that the scale is useful to measure pain in non communicative patients suffering from dementia. The scale maintains good levels of reliability for different healthcare professionals even when they have little training.

Evaluación breve del estado cognitivo de la demencia en estadios avanzados: resultados preliminares de la validación española del Severe Mini-Mental State Examination / Short evaluation of cognitive state in advanced stages of dementia: preliminary results of the Spanish validation of the Severe Mini-Mental State Examination

Introducción. La evaluación cognitiva de pacientes con demencias avanzadas es una necesidad no cubierta de forma adecuada, por lo que es necesario desarrollar herramientas que permitan obtener información del estado cognitivo y los recursos con los que aún cuentan estos sujetos. El presente trabajo realiza el estudio de validación al castellano de la escala Severe Mini-Mental State Examination (SMMSE). Material y métodos. Participaron 47 sujetos con demencia avanzada (Mini-Examen Cognoscitivo [MEC] < 11), evaluados con las escalas Global Deterioration Scale de Reisberg, MEC, SMMSE y Severe Cognitive Impairment Profile. Resultados. Todos los ítems que componen la prueba mostraron una buena capacidad de diferenciación. La prueba mostró una alta consistencia interna (α=0,88), y buena fiabilidad test-retest (0,64-1,00; p<0,01) e interjueces (0,69-1,00; p<0,01), tanto para la puntuación total como para cada uno de los ítems. La validez de constructo se analizó mediante la correlación con el MEC (r=0,59; p<0,01). Además, se dividió la muestra entre sujetos con MEC 0-5 y MEC>5, hallando que la correlación entre las puntuaciones en SMMSE y MEC era significativa en el grupo de MEC 0-5 (r=0,55; p<0,05), mientras que no lo era en aquellos con MEC>5. Asimismo se encontraron diferencias de puntuación en SMMSE, pero no en MEC, entre los tres grupos de GDS (5, 6 y 7) (H=11,1; p<0,05). Conclusiones. El SMMSE es un instrumento de evaluación del deterioro cognitivo avanzado que amplía el rango inferior de medida del MEC evitando el «efecto suelo». A partir de nuestros resultados el instrumento puede ser considerado válido y fiable, así como rápido y fácil de administrar(AU)

Introduction. The cognitive assessment of patients with advanced dementia needs proper screening instruments that allow obtain information about the cognitive state and resources that these individuals still have. The present work conducts a Spanish validation study of the Severe Mini Mental State Examination (SMMSE). Material and methods. Forty-seven patients with advanced dementia (Mini-Cognitive Examination [MEC]<11) were evaluated with the Reisberg's Global Deterioration Scale, MEC, SMMSE and Severe Cognitive Impairment Profile scales. Results. All test items were discriminative. The test showed high internal (α=0.88), test-retest (0.64 to 1.00, P<.01) and between observers reliabilities (0.69-1.00, p<0.01), both for scores total and for each item separately. Construct validity was tested through correlations between the instrument and MEC scores (r=0.59, P< 0 .01). Further information on the construct validity was obtained by dividing the sample into groups that scored above or below 5 points in the MEC and recalculating their correlations with SMMSE. The correlation between the scores in the SMMSE and MEC was significant in the MEC 0-5 group (r=0.55, P<.05), but not in the MEC>5 group. Additionally, differences in scores were found in the SMMSE, but not in the MEC, between the three GDS groups (5, 6 and 7) (H=11.1, P<.05). Conclusions. The SMMSE is an instrument for the assessment of advanced cognitive impairment which prevents the floor effect through an extension of lower measurement range relative to that of the MEC. From our results, this rapid screening tool and easy to administer, can be considered valid and reliable(AU)

[Short evaluation of cognitive state in advanced stages of dementia: preliminary results of the Spanish validation of the Severe Mini-Mental State Examination]. / Evaluación breve del estado cognitivo de la demencia en estadios avanzados: resultados preliminares de la validación española del Severe Mini-Mental State Examination.

INTRODUCTION: The cognitive assessment of patients with advanced dementia needs proper screening instruments that allow obtain information about the cognitive state and resources that these individuals still have. The present work conducts a Spanish validation study of the Severe Mini Mental State Examination (SMMSE). MATERIAL AND METHODS: Forty-seven patients with advanced dementia (Mini-Cognitive Examination [MEC]<11) were evaluated with the Reisberg's Global Deterioration Scale, MEC, SMMSE and Severe Cognitive Impairment Profile scales. RESULTS: All test items were discriminative. The test showed high internal (α=0.88), test-retest (0.64 to 1.00, P<.01) and between observers reliabilities (0.69-1.00, p<0.01), both for scores total and for each item separately. Construct validity was tested through correlations between the instrument and MEC scores (r=0.59, P<0.01). Further information on the construct validity was obtained by dividing the sample into groups that scored above or below 5 points in the MEC and recalculating their correlations with SMMSE. The correlation between the scores in the SMMSE and MEC was significant in the MEC 0-5 group (r=0.55, P<.05), but not in the MEC>5 group. Additionally, differences in scores were found in the SMMSE, but not in the MEC, between the three GDS groups (5, 6 and 7) (H=11.1, P<.05). CONCLUSIONS: The SMMSE is an instrument for the assessment of advanced cognitive impairment which prevents the floor effect through an extension of lower measurement range relative to that of the MEC. From our results, this rapid screening tool and easy to administer, can be considered valid and reliable.

A randomized, two-year study of the efficacy of cognitive intervention on elderly people: the Donostia Longitudinal Study.

BACKGROUND: Research on non-pharmacological therapies (cognitive rehabilitation) in old age has been very limited, and most has not considered the effect of interventions of this type over extended periods of time. OBJECTIVE: To investigate a new cognitive therapy in a randomized study with elderly people who did not suffer cognitive impairment. METHODS: The efficacy of this therapy was evaluated by means of post-hoc analysis of 238 people using biomedical, cognitive, behavioural, quality of life (QoL), subjective memory, and affective assessments. RESULTS: Scores for learning potential and different types of memory (working memory, immediate memory, logic memory) for the treatment group improved significantly relative to the untreated controls. CONCLUSIONS: The most significant finding in this study was that learning potential continued at enhanced levels in trained subjects over an intervention period lasting two years, thereby increasing rehabilitation potential and contributing to successful ageing.

La demencia en España: evolución desigual entre las necesidades de los pacientes y la oferta asistencial desde la geriatría / Dementia in Spain: disparity between patients' needs and healthcare provision by geriatric services

Objetivo: Estudio de la metodología empleada en el diagnóstico de las demencias en España y valoración del tratamiento más frecuente desde el punto de vista de la geriatría. Material y método: Se realizó un censo exhaustivo, cerrado el 31-10-2004, de recursos asistenciales para la atención geriátrica especializada de la demencia. Posteriormente, se realizó un estudio transversal. Los centros fueron distribuidos y validados por representantes autonómicos de la Sociedad Española de Geriatría y Gerontología (SEGG). Resultados: En general, el programa de atención a la demencia más utilizado en España es la psicoestimulación (el 59% de los centros), mientras que el principal protocolo específico es el de nutrición (el 81% de los centros), seguido por el de movilidad y cribado de depresión (el 75 y el 73%, respectivamente). Los tratamientos farmacológicos más difundidos entre los centros españoles son los fármacos anticolinesterásicos y los neurolépticos, usados en el 33 y el 32% de los pacientes, respectivamente. Además, los principios activos específicos para la demencia más utilizados son: donepezilo, rivastigmina y memantina (el 12, el 11 y el 8% de los pacientes, respectivamente). Conclusiones: La atención especializada de la demencia en España presenta una alta heterogeneidad entre centros, lo que implica una variabilidad importante de la calidad asistencial que reciben los pacientes con demencias. Así, el tratamiento de los pacientes es uno de los puntos que se debe mejorar. Los hospitales son los centros en los que se trata de manera específica a los pacientes demenciados empleando anticolinesterásicos. Por el contrario, en las residencias y otros centros se tiende a utilizar fármacos neurolépticos

Objective: To study the methodology employed for the diagnosis of dementia in Spain and to evaluate the most commonly used pharmacologic treatments in geriatric services. Material and method: We performed a descriptive, cross-sectional study. The health facilities for the specialized geriatric care of dementia in Spain were included in an exhaustive census closed on 31st October, 2004. The centers were classified and corroborated by representatives from the autonomous communities forming part of the Spanish Society of Geriatrics and Gerontology. Results: In general, the most frequently used therapeutic modality for dementia in Spain is psychostimulation (59% of the centers), while the main specific protocol is nutrition (81% of the centers), followed by mobility and early detection of depression (75% and 73%, respectively). The main pharmacological treatment in Spanish centers is the use of acetylcholinesterase inhibitors (33% of patients) and neuroleptic drugs (32% of patients). The drugs most commonly used are donepezil, rivastigmine and memantine (12%, 11% and 8% of patients, respectively). Conclusions: The specialized care of dementia in Spain shows wide heterogeneity among centers, suggesting substantial variation in the quality of care received by these patients. Thus, the treatment of patients with dementia is one of the points that should be improved. Hospitals tend to treat patients with dementia with specific treatment consisting of acetylcholinesterase inhibitors. In contrast, nursing homes and other centers tend to use neuroleptic drugs

Open-label, observational study of the effects of risperidone on the behavioral and psychological symptoms of dementia and caregiver stress in the community setting.

BACKGROUND: Behavioral disturbances and psychological symptoms of dementia--such as agitation, aggression, and psychosis--compromise patients' quality of life and daily functioning as well as contribute to caregiver burden and the decision to institutionalize the relative with the disease. OBJECTIVE: The goal of this study was to examine the effects of risperidone on noncognitive symptoms and caregiver burden in the community setting. The tolerability of risperidone was also assessed. METHODS: This was an observational, open-label, multicenter study. Dementia patients with behavioral and psychological symptoms received risperidone for 3 months. At 1 and 3 months, physicians rated symptoms on the Neuropsychiatric Inventory (NPI) and the Clinical Global Impression of Severity (CGI-S) scale. Caregivers rated their distress in relation to individual NPI items using the NPI Caregiver Distress (NPI-D) scale. Outcome variables were analyzed using Friedman and Wilcoxon tests. RESULTS: A total of 263 patients (mean age, 77.5 years) received a mean (SD) risperidone dose of 1.4 (0.7) mg/d at 1 month and 1.5 (0.8) mg/d at 3 months. The total NPI score (mean [SEM]) decreased from 33.7 (1.91) at baseline to 11.9 (0.98) at month 3 (P < 0.01), and the NPI-D score decreased from 22.5 (1.02) at baseline to 9.0 (0.64) at month 3 (P < 0.01). Agitation/aggression and sleep disturbances were the most improved symptoms and caused the largest decrease in caregiver burden. Improvements were also noted on the CGI-S scale (from 4.0 at baseline to 3.4 at month 3; P < 0.01). Extrapyramidal symptoms decreased significantly (P < 0.05) over the course of the study. CONCLUSIONS: In this study of community-based patients with dementia, risperidone significantly improved behavioral and psychological symptoms and, as a result, also reduced caregiver burden. Risperidone was well tolerated in this elderly population, particularly with regard to extrapyramidal symptoms.